SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-19-254842
Filing Date
2019-09-25
Accepted
2019-09-25 17:31:04
Documents
2
Group Members
OAKTREE CAPITAL GROUP HOLDINGS GP, LLCOAKTREE CAPITAL GROUP, LLCOAKTREE CAPITAL II, L.P.OAKTREE FUND GP II, L.P.OAKTREE FUND GP IIA, LLCOAKTREE HOLDINGS, INC.OAKTREE SPECIALTY LENDING CORPOAKTREE STRATEGIC INCOME II, INC.OCSL SRNE, LLCSC INVESTMENTS E HOL

Document Format Files

Seq Description Document Type Size
1 SC 13G d797139dsc13g.htm SC 13G 227584
2 EX-99.1 d797139dex991.htm EX-99.1 22510
  Complete submission text file 0001193125-19-254842.txt   252255
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Subject) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-82540 | Film No.: 191115025
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 333 S GRAND AVE 28TH FL LOS ANGELES CA 90071
Business Address 333 S GRAND AVENUE 28TH FL LOS ANGELES CA 90071 2138306300
OAKTREE CAPITAL MANAGEMENT LP (Filed by) CIK: 0000949509 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G